Altimmune (ALT) Amortizatization of Intangibles (2016 - 2026)
Altimmune's (ALT) quarterly Amortizatization of Intangibles came in at $870000.0 in Q1 2026, up 26.82% year-on-year from $686000.0 in Q1 2025, and down 4.5% on a QoQ basis from $911000.0 in Q4 2025.
Altimmune (ALT) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Altimmune (ALT) has 9 years of Amortizatization of Intangibles data on file, last reported at $870000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 26.82% year-over-year to $870000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 32.23% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 42.23% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $870000.0, down from $911000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ALT reached as high as $1.1 million in Q2 2024 and fell as low as $196000.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $724230.8 across 4 years, with a median of $695000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles surged 104.37% in 2024 and slumped 79.98% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $695000.0 in 2023, then increased by 17.84% to $819000.0 in 2024, then rose by 11.23% to $911000.0 in 2025, then decreased by 4.5% to $870000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $870000.0 in Q1 2026, $911000.0 in Q4 2025, and $196000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Altimmune | 374.63 Mn | 374.63 Mn | - | 870,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 870,000.00 |
| Mar 31, 2026 | 870,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Dec 31, 2025 | 911,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Jun 30, 2025 | 431,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 983,000.00 |
| Mar 31, 2024 | 983,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Dec 31, 2023 | 695,000.00 |